The chronic obstructive pulmonary disease market size was valued at US$ 21.6 billion in 2023 and is predicted to reach US$ 33.29 billion by the end of 2033, representing an impressive CAGR of 4.42% from 2024 to 2033.
Download a sample of this report @ https://www.towardshealthcare.com/download-statistics/5154
Key Takeaways
- By region, North America dominated the chronic obstructive pulmonary disease market in 2023.
- By region, Asia Pacific is estimated to grow at the fastest rate during the forecast period.
- By disease type, the chronic bronchitis segment dominated the market in 2023.
- By treatment type, the drugs segment dominated the market in 2023.
- By treatment type, the oxygen therapy segment is expected to grow at the fastest rate during the forecast period.
- By end-user, the hospital & clinics segment dominated the market in 2023.
Industry at a Glance
The chronic obstructive pulmonary disease market revolves around all the aspects associated with COPD, which are research & development, drug development, process development, diagnosis, treatment, monitoring, and post-treatment care. Chronic obstructive lung disease, or COPD, is a common lung disorder that reduces airflow and causes breathing difficulties. COPD patients may develop lung damage or phlegm accumulation. The symptoms include coughing, wheezing, exhaustion, and sometimes even phlegm.
Tobacco and air pollution are the two primary causes of COPD. While there is no known treatment for COPD, a person’s symptoms may improve if they give up smoking, shield themselves from air pollution, and become immunized to ward against infections. It can also be treated with oxygen, drugs, and pulmonary rehabilitation. Because chronic obstructive pulmonary disease cannot be cured and needs ongoing medication, therapy, and monitoring, the market for this condition is always expanding. The growing prevalence is also increasing due to the high amount of smoking, pollution, and occupational hazards.
Top Companies of the Chronic Obstructive Pulmonary Disease Market
- Almirall
- Abbott Laboratories
- Dr. Reddy’s Laboratories Ltd.
- AstraZeneca
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline
- Boehringer Ingelheim
- Pfizer Inc.
- Astellas Pharma
- Novartis AG
- Merck & Co., Inc.
Segments Covered in the Chronic Obstructive Pulmonary Disease Market Report
Disease Type
- Emphysema
- Chronic Bronchitis
Treatment Type
- Drugs
- Bronchodilator Monotherapy
- Short-Acting Beta2-Agonists (SABAs)
- Long-Acting Beta2-Agonists (LABAs)
- Anti-Inflammatory Drugs
- Oral And Inhaled Corticosteroids
- Anti-Leukotrienes
- Surgery
- Lung Volume Reduction Surgery (LVRS)
- Lung Transplant
- Bullectomy
- Others
- Oxygen Therapy
End User Type
- Hospitals & Clinics
- Homecare Settings
- Others
Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/chronic-obstructive-pulmonary-disease-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5154
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
